Harpoon Therapeutics (HARP) News Today → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free HARP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMerck raises 2024 profit forecast on surging sales of cancer drug Keytrudamsn.com - April 25 at 6:50 PMHARP Apr 2024 20.000 putfinance.yahoo.com - March 16 at 7:49 AMHARP Sep 2024 20.000 putfinance.yahoo.com - March 16 at 7:49 AMShort Interest in Harpoon Therapeutics, Inc. (NASDAQ:HARP) Declines By 53.6%marketbeat.com - March 13 at 2:36 PMAnalysts Are Bullish on Top Healthcare Stocks: Biogen (BIIB), Merck & Company (MRK)markets.businessinsider.com - March 13 at 1:51 PMMerck completes acquisition of Harpoon Therapeuticsmsn.com - March 12 at 2:54 PMHarpoon Therapeutics, Inc. (NASDAQ:HARP) Major Shareholder Buys $492,135,715.00 in Stockinsidertrades.com - March 12 at 4:24 AMMerck & Co., Inc. Acquires 21,397,205 Shares of Harpoon Therapeutics, Inc. (NASDAQ:HARP) Stockmarketbeat.com - March 11 at 4:24 PMHarpoon Therapeutics, Inc. (NASDAQ:HARP) Position Lessened by Kennedy Capital Management LLCmarketbeat.com - March 11 at 7:07 AMmarketbeat.com - March 11 at 6:10 AMAnalysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA), Brainsway (BWAY) and Wave Life Sciences (WVE)markets.businessinsider.com - March 7 at 5:11 PMHarpoon Therapeutics ticks higher amid Nasdaq delisting notice for sale to Merckmsn.com - March 6 at 5:40 PMAcadian Asset Management LLC Sells 69,040 Shares of Harpoon Therapeutics, Inc. (NASDAQ:HARP)marketbeat.com - March 6 at 5:17 AMHarpoon Therapeutics, Inc. (NASDAQ:HARP) Shares Sold by MPM Bioimpact LLCmarketbeat.com - March 1 at 10:26 AMCitigroup Downgrades Harpoon Therapeutics (HARP)msn.com - February 27 at 6:09 PMAnalyst Scoreboard: 4 Ratings For Harpoon Therapeuticsmarkets.businessinsider.com - February 26 at 5:08 PMHarpoon Therapeutics (NASDAQ:HARP) Rating Reiterated by Citigroupmarketbeat.com - February 26 at 12:21 PMHarpoon Therapeutics just downgraded at Citi, here's whyrealmoney.thestreet.com - February 24 at 3:43 AMFate of US Aid to Ukraine Package Discussed on Taiwan Trip, Lawmakers Sayusnews.com - February 23 at 7:05 AMMerck wins EU backing for Keytruda use in resectable lung cancermsn.com - February 23 at 7:05 AMHARPOON THERAPEUTICS (5HTA.BE)finance.yahoo.com - February 23 at 7:05 AMHarpoon Therapeutics Inc. (5HTA.SG)finance.yahoo.com - February 23 at 7:05 AMStock (HARP), Short Interest Reportbenzinga.com - February 22 at 9:05 PMHarpoon Therapeutics, Inc. (NASDAQ:HARP) Short Interest Up 15.2% in Januarymarketbeat.com - February 17 at 12:48 AMAnalysts Are Bullish on Top Healthcare Stocks: Immunovant (IMVT), 4D Molecular Therapeutics (FDMT)markets.businessinsider.com - February 13 at 10:04 AMMerck Hasn't Even Closed Its Last Buyout, But It's Already Hunting For The Next Dealmsn.com - February 1 at 5:07 PMWhile private equity firms own 20% of Harpoon Therapeutics, Inc. (NASDAQ:HARP), retail investors are its largest shareholders with 36% ownershipfinance.yahoo.com - January 30 at 10:39 AMArix Bioscience PLC: Financial update on Harpoon Therapeutics acquisition by Merck (MSD)finanznachrichten.de - January 19 at 10:27 AMMerck, the Dow's hottest stock, gets set to report Q4 financials (HARP)marketbeat.com - January 18 at 9:30 AMPeeling Back The Layers: Exploring Harpoon Therapeutics Through Analyst Insightsmarkets.businessinsider.com - January 16 at 6:17 PMHarpoon Therapeutics (NASDAQ:HARP) Given "Market Perform" Rating at TD Cowenmarketbeat.com - January 16 at 3:33 PMEquities Analysts Issue Forecasts for Harpoon Therapeutics, Inc.'s FY2028 Earnings (NASDAQ:HARP)marketbeat.com - January 11 at 8:43 AMMerck Stock Gains After Snatching Harpoon Therapeuticsbaystreet.ca - January 11 at 8:35 AMHarpoon Therapeutics (NASDAQ:HARP) Downgraded by Leerink Partnrs to "Market Perform"marketbeat.com - January 10 at 7:28 AMMerck Buys Harpoon Therapeutics To Expand Its Oncology Portfoliomsn.com - January 9 at 3:53 PMMerck (MRK) to Strengthen Cancer Pipeline With Harpoon Buyoutfinance.yahoo.com - January 9 at 10:44 AMHarpoon Therapeutics (NASDAQ:HARP) Given Neutral Rating at HC Wainwrightmarketbeat.com - January 8 at 2:28 PMBoeing, Alaska Air Group fall; Harpoon Therapeutics, Axonics rise, Monday, 1/8/2024marketbeat.com - January 8 at 12:21 PMWhy Is Harpoon Therapeutics (HARP) Stock Up 111% Today?investorplace.com - January 8 at 9:06 AMMerck In Talks To Acquire Harpoon Therapeutics: Reportsmarkets.businessinsider.com - January 8 at 7:50 AMHarpoon Therapeutics Shares Take Flight Premarket on Report of Merck Deal Talksmarketwatch.com - January 8 at 7:50 AMHarpoon Therapeutics, Heron Therapeutics And Other Big Stocks Moving Higher In Monday's Pre-Market Sessionmarkets.businessinsider.com - January 8 at 7:50 AMWhy Is Cancer Focused Harpoon Therapeutics Stock Shooting Higher Today?benzinga.com - January 8 at 7:50 AMBiggest stock movers today: Boeing, Harpoon Therapeutics, and moremsn.com - January 8 at 7:50 AMMerck to Acquire Harpoon Therapeutics, Further Diversifying Oncology Pipelinefinance.yahoo.com - January 8 at 7:50 AMMerck to buy Harpoon Therapeutics for $680 millionca.finance.yahoo.com - January 8 at 7:50 AMMerck in talks to buy Harpoon Therapeutics for around $700 million - Bloomberg Newsnews.yahoo.com - January 8 at 1:01 AMMerck Is in Advanced Talks to Buy Cancer Drugmaker Harpoon Therapeuticsmsn.com - January 8 at 1:01 AMMerck in talks to buy Harpoon Therapeutics for around $700 mln - Bloomberg Newsreuters.com - January 8 at 1:01 AMOppenheimer Initiates Coverage of Harpoon Therapeutics (HARP) with Outperform Recommendationmsn.com - January 6 at 7:32 AM Get Harpoon Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HARP and its competitors with MarketBeat's FREE daily newsletter. Email Address Move Your Money Before May 1 (Ad)Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. HARP Media Mentions By Week HARP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HARP News Sentiment▼0.530.33▲Average Medical News Sentiment HARP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HARP Articles This Week▼12▲HARP Articles Average Week Get Harpoon Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HARP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SLDB News STTK News CRBP News NKTR News CELC News ACRV News MACK News STOK News IMMP News THRX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HARP) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsMan Who Predicted 2008: “This Will be Worse.”AltimetryEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harpoon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
